PD pathophysiology is often ascribed to the decline in glucose metabolism regulation, the decreased sensitivity of insulin in insulin-dependent tissues, and the subsequent dysfunction of pancreatic β-cells, resulting in hyperglycemia and the overall dysregulation of insulin [23,24]. The gene discussed is INS; the disease is Hyperglycemia.